永和智控“大撤退” 三折甩卖第四家民营肿瘤医院

Core Points - Yonghe Zhikong plans to publicly transfer 100% equity of Kunming Medical Oncology Hospital with a minimum listing price of 35.93 million yuan, marking a complete exit from the healthcare sector after divesting all four private hospitals since 2020 [2] - The acquisition of Kunming Medical was made in 2020 for 108 million yuan, resulting in goodwill of 71.15 million yuan, with the current listing price reflecting a discount of approximately 70% compared to the initial acquisition cost [2] - The company has also listed for sale the equity stakes of its other hospitals, including Dazhou Medical Oncology Hospital (95% stake at 27.68 million yuan), Liangshan High-tech Oncology Hospital (70% stake at 9.37 million yuan), and Xi'an Medical Oncology Hospital (73% stake) along with a debt claim of 14.93 million yuan [2] - The divestment aims to optimize the company's industrial structure and improve the quality of development [2] Financial Performance - After the acquisition, both Kunming Medical and Xi'an Medical reported losses in 2022, while Dazhou Medical and Liangshan High-tech also faced losses in 2023, with all four hospitals continuing to incur losses into the first half of 2024 [3]